Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;30(1):114-20.
doi: 10.1007/s10637-010-9530-3. Epub 2010 Sep 7.

Cytotoxic activity of the titanium alkoxide (OPy)(2)Ti(4AP)(2) against cancer colony forming cells

Affiliations

Cytotoxic activity of the titanium alkoxide (OPy)(2)Ti(4AP)(2) against cancer colony forming cells

Elizabeth A Williamson et al. Invest New Drugs. 2012 Feb.

Abstract

A novel family of titanium alkoxides with two stable pyridinemethoxide moieties bound to a titanium metal center were synthesized and tested for cytotoxic activity on a variety of cancer cell lines using colony formation assays. One compound, (OPy)(2)Ti(4AP)(2), where OPy is NC(5)H(5)CH(2)O(-), and 4AP is 4-aminophenoxide ((-)OC(6)H(5)(NH(2))-4), demonstrated increased cytotoxicity in breast, colon, and pancreatic cancer cell lines at 100 nanomolar levels with only short exposures. Further, (OPy)(2)Ti(4AP)(2) had activity in colon and pancreatic cancer cell lines that are usually resistant to chemotherapy. This demonstrates that these titanium compounds may have a role in anti-cancer therapy, similar to platinum-based compounds, and the (OPy)(2)Ti(4AP)(2) compound specifically deserves further investigation as an anti-cancer agent in chemo-resistant solid tumors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The structure of (OPy)2Ti(4AP)2 (10). a Unit cell view of the 3-dimensional structure of (OPy)2Ti(4AP)2. The titanium is represented by green, oxygen by red, nitrogen by blue, and carbon by grey. Hydrogen atoms have been removed for clarity. b The Schematic structure of (OPy)2Ti(4AP)2
Fig. 2
Fig. 2
The effect of (OPy)2Ti(4AP)2 on pancreatic cancer cell lines. a Panc1, b BxPC3, and c McCain’s nut. Indicated cell numbers were adhered to culture dishes, exposed to varying nM concentrations of compound for 4 h, then washed, and incubated for 10–14 days for colony formation. Each experiment was performed twice in triplicate, with standard error of the mean indicated. Colony survival was compared to the plating efficiency of cells treated with vehicle alone as a control. Statistical differences at the p <0.05 level using Student’s t test between test and control cells is indicated by a star
Fig. 3
Fig. 3
The effect of (OPy)2Ti(4AP)2 on breast cancer cell lines. a T47D, b MFC7, c MCF10a, and d MDA-MB-231. Indicated cell numbers were adhered to culture dishes, exposed to varying nM concentrations of compound for 4 h, then washed, and incubated for 10–14 days for colony formation. Each experiment was performed twice in triplicate, with standard error of the mean indicated. Colony survival was compared to the plating efficiency of cells treated with vehicle alone as a control. Statistical differences at the p <0.05 level using Student’s t test between test and control cells is indicated by a star
Fig. 4
Fig. 4
The effect of (OPy)2Ti(4AP)2 on colon cancer cell lines. a SW48, b CaCo2, c HT29 and d T84. Indicated cell numbers were adhered to culture dishes, exposed to varying nM concentrations of compound for 4 h, then washed, and incubated for 10–14 days for colony formation. Each experiment was performed twice in triplicate, with standard error of the mean indicated. Colony survival was compared to the plating efficiency of cells treated with vehicle alone as a control. Statistical differences at the p <0.05 level using Student’s t test between test and control cells is indicated by a star

Similar articles

Cited by

References

    1. Wohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer. 1998;34:1522–1534. - PubMed
    1. Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment. Crit Rev Oncol Hematol. 2002;42:317–325. - PubMed
    1. Kelland L. The resurgence of platinum-based cancer chemotherapy. Clin Cancer Res. 2007;13:4960–4963. - PubMed
    1. Caruso F, Rossi M. Antitumor titanium compounds. Mini Rev Med Chem. 2004;4:49–60. - PubMed
    1. Harding MM, Mokdsi G. Antitumour metallocenes: structure-activity studies and interactions with biomolecules. Curr Med Chem. 2000;7:1289–1303. - PubMed

Publication types

MeSH terms

Substances